Healthy people do not need to take clopidogrel every day, clinically for the high risk of bleeding in the Asian population, or just occurred gastrointestinal bleeding patients resumption of antiplatelet therapy is oral clopidogrel 50mg / day.
Clopidogrel is an antiplatelet aggregation drug, mainly for acute myocardial infarction, stroke, abdominal aortic sclerosis and other peripheral arterial diseases, the recommended oral dose of 75mg/day, can prevent thrombosis, clinically for the high risk of bleeding in Asian populations, or just occurred in gastrointestinal bleeding of the patient resumption of antiplatelet therapy can be orally clopidogrel 50mg/day.
For the combination of peptic ulcer, cerebral hemorrhage, gastric hemorrhage and other active bleeding or allergic patients, should be prohibited from use. Common adverse reactions to taking clopidogrel include causing skin purpura, nosebleeds, hematuria and other bleeding and other idleness, abdominal pain, belching and other gastrointestinal reactions, aplastic anemia and other blood disorders, eczema and other skin diseases.
If a patient needs to take clopidogrel, it is recommended to visit a hospital and should be guided by a doctor’s assessment.